One study found that the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene may lessen the epilepsy phenotype in FXS patients, as this polymorphism can affect cerebral anatomy [104] and fragile X-associated neuropsychiatric disorders (FXAND) [99–107]. Here, BDNF is linked to epilepsy.